You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 376 to 400 of about 5865
Next 25
11/16/2022
xCures presents clinical and translational research with two posters at the 2022 SNO Annual Meeting
CTIM-27. AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACCINATION IMPROVES SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA: SURVIVAL RESULTS FROM A PHASE 3 TRIAL
11/14/2022
Starving Cancer Cells Without Starving You
First Patient Enrolled in Phase 1 Study of MTX-110 (MAGIC-G1 Study) in Patients with Recurrent Glioblastoma
Musella Foundation collaborates with the DIPG/DMG Collaborative to give out $198,436 grant for a low side effect innovative clinical trial for DIPG/DMG
Giving Tuesday Contest
11/13/2022
Souped-up oncolytic virus warms up cold brain cancer tumors
11/12/2022
Candel Therapeutics Announces Late-Breaking Oral Presentation at SITC Annual Meeting
11/11/2022
Alpheus Medical Treats First Patients in First-In-Human Clinical Trial for Novel High-Grade Glioma Brain Cancer Treatment
Novocure Secures CE Mark for New Array
Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study
11/09/2022
Starting with ADC, FDA calls for fully enrolled confirmatory trial prior to accelerated approval submission
Navigating Emotional Wellbeing as a GBM Caregiver: A Conversations with Mental Health Experts
11/08/2022
Step taken towards non-surgical treatment for schwannomas
11/07/2022
Reminder: Webinar tonight (11/7/22 at 7pm Eastern) on Sonodynamic Therapy for Brain Tumors
11/04/2022
OKN-007 Expanded Access for Pediatric Patients with Diffuse Midline Glioma(including DIPG)
Finally, cancer patients have real-time access to their medical records
Webinar on Sonodynamic Therapy for the Treatment of Malignant Glioma to be presented Monday, Nov 7, 2022
10/27/2022
Walmart.com selects the Musella Foundation for it`s new charity program!
New Edition Of our Brain Tumor Guide For The Newly Diagnosed is now available!
10/25/2022
NeedyMeds Webinars
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Novocure Launches Campaign to Drive Awareness and Understanding of Tumor Treating Fields Therapy
10/19/2022
Determinants of tumor treating field usage in patients with primary glioblastoma: A single institutional experience